ANTIPROLIFERATIVE AND APOPTOGENIC EFFICACY OF ANTIDIABETIC DRUGS METFORMIN AND SITAGLIPTIN AGAINST MCF7 AND HEPG2 CANCER CELLS: A COMPARATIVE MOLECULAR STUDY
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 6
Abstract
Lifestyle and diet-related disorder type 2 diabetes (T2D), has reached epidemic margin globally. The relationships between diabetes and cancer are complex. However, evidence supports the hypothesis that obesity raises the risks of both T2D and certain cancers. A further complication arises from the controversy that drugs used in the treatment of T2D increase or decrease cancer risk or influence cancer diagnosis. Herein, we hypothesized that the antidiabetic medications can improve cancer outcome. In this study, we have studied the potency and efficacy of two well-known antidiabetic drugs metformin and sitagliptin. Although there are controversies for the usage of DDP4 inhibitors, we found that sitagliptin has a potent cytotoxic effect on both type of cancer cells (MCF7 and HepG2). It has also shown certain impact on early apoptogenic efficacy in HepG2 and late apoptogenic efficacy on MCF7 as well as the caspase-3 activity expression in both cell lines. In the line of our study, it might be concluded that sitagliptin has significant antiproliferative and apoptogenic efficacy in MCF7 and HepG2 cancer cells, though it was observed to be lesser than that of metformin. Further thorough investigation in a cancer-diabetes animal model, as well as the trial on cancer-diabetic human subjects, is required to establish the efficacy of type 2 antidiabetic drugs in treating diabetic cancer patients.
Authors and Affiliations
Mrinmoy Sarkar
Keywords
Related Articles
- EP ID EP296579
- DOI 10.22270/jddt.v7i6.1519
- Views 91
- Downloads 0
THE ROLE OF CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER
Breast cancer (BC) is the most frequent tumor worldwide. Triple-negative BCs are characterized by the negative estrogen and progesterone receptors and negative HER2, and represent 12-18% of all BCs.Breast cancer (breast...
PREPARATION AND CHARACTERIZATION OF ISONIAZID CHITOSAN LOADED NANOPARTICLES
Although the part that we live in, is an age of creative technology and modernization, infectious diseases, like Tuberculosis (TB), still remain to be one of the greatest health challenges worldwide. The objective of thi...
FORMULATION AND DEVELOPMENT OF SUSTAINED RELEASE MATRIX TABLETS OF LORNOXICAM
Lornoxicam is a NSAID having oxicam class mainly prescribed in the treatment of osteoarthritis and rheumatoid arthritis. NSAID have the potential to relieve the pain and inflammation without the immunosuppressive and met...
EVALUATION OF CYTOPROTECTIVE EFFICACY OF ARISAEMA LESCHNAULTII BLUME AGAINST CYCLOPHOSPHAMIDE INDUCED HEPATOTOXICITY IN TUMOR BEARING MICE
Cyclophosphamide (CP) is a widely used antineoplastic drug, it is used for the treatment of several malignancies. However, upon treatment, it induces severe toxicity due to its oxidative stress capability In this study...
MEMORY ENHANCING ACTIVITY OF HYDROALCOHOLIC EXTRACT OF TERMINALIA CATAPPA LEAVES
The present study was to evaluate the effect of Terminalia catappa on cognitive functions and cholinesterase (ChE) activity in scopolamine-induced amnesia in rats. The extract of Terminalia catappa was administered orall...